← Back to Search

Behavioural Intervention

Injury Thrivorship Pathway for Traumatic Injury

N/A
Waitlist Available
Led By Marissa A Boeck, MD, MPH
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year
Awards & highlights

Study Summary

This trial aims to test a new program for injury survivors to see if it meets their medical and social needs. Participants will be interviewed and their use of the program will be monitored.

Who is the study for?
This trial is for individuals who have survived physical trauma and are navigating their recovery. It's designed to assess a new support pathway tailored to both medical and social needs of these survivors. Participants should be willing to engage in interviews and allow tracking of their use of the provided resources.Check my eligibility
What is being tested?
The study is testing a 'Human-Centered Injury Thrivorship Pathway' which aims to help injury survivors with their recovery process. The focus is on determining if this pathway is suitable, well-received, and practical for addressing the comprehensive needs of these individuals.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like support pathways rather than drugs or medical procedures, traditional side effects are not applicable. However, participants may experience emotional or psychological impacts from discussing their trauma during interviews.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Early Implementation Outcomes - Acceptability, Appropriateness, Feasibility
Secondary outcome measures
Participant pathway resource utilization - % utilized
Participant pathway resource utilization - duration
Participant pathway resource utilization - frequency
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Injury Thrivorship PathwayExperimental Treatment1 Intervention
Enrollment in the human-centered injury thrivorship pathway.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,530 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
321 Previous Clinical Trials
401,724 Total Patients Enrolled
Marissa A Boeck, MD, MPHPrincipal InvestigatorUniversity of California, San Francisco

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the current clinical trial open for new participant enrollment?

"As per clinicaltrials.gov, this research investigation is currently not in the recruitment phase. The trial was first made public on July 1st, 2025, and last updated on February 27th, 2024. Despite its current inactive status regarding participant enrollment, there are a noteworthy total of 844 other ongoing studies welcoming new candidates at present."

Answered by AI
~17 spots leftby Apr 2026